198 related articles for article (PubMed ID: 19902527)
1. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo.
Banno B; Ickenstein LM; Chiu GN; Bally MB; Thewalt J; Brief E; Wasan EK
J Pharm Sci; 2010 May; 99(5):2295-308. PubMed ID: 19902527
[TBL] [Abstract][Full Text] [Related]
2. Materials characterization of the low temperature sensitive liposome (LTSL): effects of the lipid composition (lysolipid and DSPE-PEG2000) on the thermal transition and release of doxorubicin.
Needham D; Park JY; Wright AM; Tong J
Faraday Discuss; 2013; 161():515-34; discussion 563-89. PubMed ID: 23805756
[TBL] [Abstract][Full Text] [Related]
3. Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes.
Sandström MC; Ickenstein LM; Mayer LD; Edwards K
J Control Release; 2005 Sep; 107(1):131-42. PubMed ID: 16023753
[TBL] [Abstract][Full Text] [Related]
4. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
[TBL] [Abstract][Full Text] [Related]
5. Influence of cholesterol inclusion on the doxorubicin release characteristics of lysolipid-based thermosensitive liposomes.
Sadeghi N; Deckers R; Ozbakir B; Akthar S; Kok RJ; Lammers T; Storm G
Int J Pharm; 2018 Sep; 548(2):778-782. PubMed ID: 29126907
[TBL] [Abstract][Full Text] [Related]
6. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149
[TBL] [Abstract][Full Text] [Related]
7. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
[TBL] [Abstract][Full Text] [Related]
8. Eutectic Resolves Lysolipid Paradox in Thermoresponsive Liposomes.
Eckhardt D; Semeraro EF; Steigenberger J; Schnur J; Kalie L; Massing U; Pabst G; Heerklotz H
Mol Pharm; 2024 Apr; 21(4):1768-1776. PubMed ID: 38381374
[TBL] [Abstract][Full Text] [Related]
9. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635
[TBL] [Abstract][Full Text] [Related]
10. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer.
Liang X; Gao J; Jiang L; Luo J; Jing L; Li X; Jin Y; Dai Z
ACS Nano; 2015 Feb; 9(2):1280-93. PubMed ID: 25599568
[TBL] [Abstract][Full Text] [Related]
11. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy.
Tagami T; May JP; Ernsting MJ; Li SD
J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351
[TBL] [Abstract][Full Text] [Related]
12. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive liposomes for triggered release of cytotoxic proteins.
de Matos MBC; Beztsinna N; Heyder C; Fens MHAM; Mastrobattista E; Schiffelers RM; Leneweit G; Kok RJ
Eur J Pharm Biopharm; 2018 Nov; 132():211-221. PubMed ID: 30223028
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
15. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
16. Engineering thermosensitive liposome-nanoparticle hybrids loaded with doxorubicin for heat-triggered drug release.
Al-Ahmady Z; Lozano N; Mei KC; Al-Jamal WT; Kostarelos K
Int J Pharm; 2016 Nov; 514(1):133-141. PubMed ID: 27863656
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Efficacy of Cisplatin Thermosensitive Liposomes upon Mild Hyperthermia in C26 Tumor Bearing BALB/c Mice.
Alavizadeh SH; Gheybi F; Nikpoor AR; Badiee A; Golmohammadzadeh S; Jaafari MR
Mol Pharm; 2017 Mar; 14(3):712-721. PubMed ID: 28135098
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
19. Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With
Santos MA; Goertz DE; Hynynen K
Theranostics; 2017; 7(10):2718-2731. PubMed ID: 28819458
[TBL] [Abstract][Full Text] [Related]
20. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
